SE0102910D0 - New use - Google Patents

New use

Info

Publication number
SE0102910D0
SE0102910D0 SE0102910A SE0102910A SE0102910D0 SE 0102910 D0 SE0102910 D0 SE 0102910D0 SE 0102910 A SE0102910 A SE 0102910A SE 0102910 A SE0102910 A SE 0102910A SE 0102910 D0 SE0102910 D0 SE 0102910D0
Authority
SE
Sweden
Prior art keywords
new use
inflamation
pharmaceutical composition
relates
oxytocin
Prior art date
Application number
SE0102910A
Other languages
English (en)
Swedish (sv)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Original Assignee
Moberg Kerstin Uvnaes
Thomas Lundeberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moberg Kerstin Uvnaes, Thomas Lundeberg filed Critical Moberg Kerstin Uvnaes
Priority to SE0102910A priority Critical patent/SE0102910D0/xx
Publication of SE0102910D0 publication Critical patent/SE0102910D0/xx
Priority to US10/488,166 priority patent/US20060234919A1/en
Priority to AU2002328000A priority patent/AU2002328000A1/en
Priority to EP02763166A priority patent/EP1432434A2/fr
Priority to PCT/SE2002/001560 priority patent/WO2003017922A2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0102910A 2001-08-31 2001-08-31 New use SE0102910D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0102910A SE0102910D0 (sv) 2001-08-31 2001-08-31 New use
US10/488,166 US20060234919A1 (en) 2001-08-31 2002-09-02 Use
AU2002328000A AU2002328000A1 (en) 2001-08-31 2002-09-02 Use of substances with oxytocin activity for the preparation of a pharmaceutical composition against inflammation
EP02763166A EP1432434A2 (fr) 2001-08-31 2002-09-02 Utilisation de substances ayant une activite d'oxytocine dans la preparation d'un medicament contre inflammation
PCT/SE2002/001560 WO2003017922A2 (fr) 2001-08-31 2002-09-02 Nouvelle utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102910A SE0102910D0 (sv) 2001-08-31 2001-08-31 New use

Publications (1)

Publication Number Publication Date
SE0102910D0 true SE0102910D0 (sv) 2001-08-31

Family

ID=20285200

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102910A SE0102910D0 (sv) 2001-08-31 2001-08-31 New use

Country Status (5)

Country Link
US (1) US20060234919A1 (fr)
EP (1) EP1432434A2 (fr)
AU (1) AU2002328000A1 (fr)
SE (1) SE0102910D0 (fr)
WO (1) WO2003017922A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
US20100204112A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
JP2010539067A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのＧｌｙ−Ｐｒｏ−Ｇｌｕ−ＯＨ（ＧＰＥ）の使用
JP2010539059A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 例えばＡＩＤＳまたはアルツハイマーの治療のための治療剤としてのβ−メラノトロピンの使用
WO2009033820A2 (fr) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
WO2009039981A2 (fr) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
WO2014057092A1 (fr) * 2012-10-12 2014-04-17 Pep-Tonic Medical Ab Nouvelle utilisation d'une composition comprenant de l'oxytocine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1528502A1 (ru) * 1982-10-18 1989-12-15 Оренбургский Государственный Медицинский Институт Способ лечени гнойно-воспалительных заболеваний
RU2145870C1 (ru) * 1998-07-06 2000-02-27 Оренбургская государственная медицинская академия Способ коррекции гипергликемии у больных сахарным диабетом с гнойно-воспалительными заболеваниями
SE9803272D0 (sv) * 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for cell regeneration
RU2157206C1 (ru) * 1999-03-10 2000-10-10 Оренбургская государственная медицинская академия Бактерицидный отогель

Also Published As

Publication number Publication date
WO2003017922A2 (fr) 2003-03-06
EP1432434A2 (fr) 2004-06-30
AU2002328000A1 (en) 2003-03-10
US20060234919A1 (en) 2006-10-19
WO2003017922A3 (fr) 2003-10-09

Similar Documents

Publication Publication Date Title
PT1193270E (pt) Pirrolobenzodiazepinas
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
PT1307457E (pt) Compostos heterociclicos sua preparacao e utilizacao como medicamentos noemadamente como antibacterianos
SE0301700D0 (sv) Novel compounds
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
UY28348A1 (es) Compuestos novedosos
NO20025450L (no) Ny farmasöytisk sammensetning
MA27026A1 (fr) Composition pharmaceutique liquide
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
FI20011478A0 (fi) Farmaseuttinen koostumus
EE05020B1 (et) Glburiidi ravimkoostis
SE9802729D0 (sv) Novel Compounds
ID26055A (id) Senyawa-senyawa hidroksidifenil eter
SV2002000776A (es) Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv
CL2004001678A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos.
PT1289366E (pt) Combinacoes fungicidas de substancias activas
SE9801494D0 (sv) Novel use
SE0102910D0 (sv) New use
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
ATE387213T1 (de) Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden
SE9803272D0 (sv) A drug for cell regeneration